Literature DB >> 10844660

Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif.

S Hammerschmidt1, M P Tillig, S Wolff, J P Vaerman, G S Chhatwal.   

Abstract

SpsA, a pneumococcal surface protein belonging to the family of choline-binding proteins, interacts specifically with secretory immunglobulin A (SIgA) via the secretory component (SC). SIgA and free SC from mouse, rat, rabbit and guinea-pig failed to interact with SpsA indicating species-specific binding to human SIgA and SC. SpsA is the only pneumococcal receptor molecule for SIgA and SC as confirmed by complete loss of SIgA and SC binding to a spsA mutant. Analysis of recombinant SpsA fusion proteins showed that the binding domain is located in the N-terminal region of SpsA. By the use of different truncated N-terminal SpsA fusion proteins, the minimum binding domain was shown to be composed of 112 amino acids (residues 172-283). The sequence of this 112-amino-acids domain was used to spot synthesize 34 overlapping peptides, consisting of 15 amino acids each, with an offset of three amino acids on a cellulose membrane. One of the peptides reacted specifically with both SIgA and SC. By using a second membrane with immobilized synthetic peptides of decreasing length containing parts of the identified 15-amino-acid motif a hexapeptide, YRNYPT was identified as the binding motif for SC and SIgA. SpsA proteins with a size smaller than the assay-positive domain of 112 amino acids were able to inhibit the interaction of SIgA and pneumococci provided they contained the binding motif. The results indicated that the hexapeptide YRNYPT located in SpsA of pneumococcal strain type 1 (ATCC 33400) between amino acids 198 and 203 is involved in SIgA and SC binding. Because synthetic peptides containing only parts of the hexapeptide also assayed positive, these results further suggest that at least the amino acids YPT of the identified hexapeptide are critical for binding to SC and SIgA. Amino acid substitutions in the identified putative binding motif abolished SC-/SIgA-binding activity of the mutated SpsA protein, confirming the functional activity of this hexapeptide and the critical role of the amino acids YPT in SC and SIgA binding. Identification of this motif, which is highly conserved in SpsA protein among different serotypes, might contribute towards a new peptide based vaccine strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844660     DOI: 10.1046/j.1365-2958.2000.01897.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  54 in total

1.  Binding of alpha2-macroglobulin to GRAB (Protein G-related alpha2-macroglobulin-binding protein), an important virulence factor of group A streptococci, is mediated by two charged motifs in the DeltaA region.

Authors:  Antonia W Godehardt; Sven Hammerschmidt; Ronald Frank; Gursharan S Chhatwal
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Impact of glutamine transporters on pneumococcal fitness under infection-related conditions.

Authors:  Tobias Härtel; Matthias Klein; Uwe Koedel; Manfred Rohde; Lothar Petruschka; Sven Hammerschmidt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells.

Authors:  Vaibhav Agarwal; Tauseef M Asmat; Shanshan Luo; Inga Jensch; Peter F Zipfel; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

4.  Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae.

Authors:  Rensheng Luo; Beth Mann; William S Lewis; Arthur Rowe; Richard Heath; Michael L Stewart; Agnes E Hamburger; Siva Sivakolundu; Eilyn R Lacy; Pamela J Bjorkman; Elaine Tuomanen; Richard W Kriwacki
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

5.  Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

Authors:  Carlos J Orihuela; Jafar Mahdavi; Justin Thornton; Beth Mann; Karl G Wooldridge; Noha Abouseada; Neil J Oldfield; Tim Self; Dlawer A A Ala'Aldeen; Elaine I Tuomanen
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

6.  Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae.

Authors:  Naoko Fuji; Michael E Pichichero; Ravinder Kaur
Journal:  Med Microbiol Immunol       Date:  2021-03-22       Impact factor: 3.402

7.  Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.

Authors:  Beth Mann; Justin Thornton; Richard Heath; Kristin R Wade; Rodney K Tweten; Geli Gao; Karim El Kasmi; John B Jordan; Diana M Mitrea; Richard Kriwacki; Jeff Maisonneuve; Mark Alderson; Elaine I Tuomanen
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

8.  The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.

Authors:  Thomas G Duthy; Rebecca J Ormsby; Eleni Giannakis; A David Ogunniyi; Uwe H Stroeher; James C Paton; David L Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Species-specific interaction of Streptococcus pneumoniae with human complement factor H.

Authors:  Ling Lu; Zhuo Ma; T Sakari Jokiranta; Adeline R Whitney; Frank R DeLeo; Jing-Ren Zhang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Pneumococcal surface protein C contributes to sepsis caused by Streptococcus pneumoniae in mice.

Authors:  Francesco Iannelli; Damiana Chiavolini; Susanna Ricci; Marco Rinaldo Oggioni; Gianni Pozzi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.